The US Hemp Production Handbook offers a high-level, concise overview of the basic rules and regulations for producing hemp in the United States.

This handbook highlights commonalities and distinctions between State/Tribal Plans and the Federal Plan. Among other topics, the handbook addresses disclosing land information, sampling and testing hemp crops, and disposing of non-compliant plants.

The U.S. Hemp Production Handbook may be viewed and downloaded here.

Print:
EmailTweetLikeLinkedIn
Photo of Christopher Gismondi Christopher Gismondi

Chris Gismondi is Of Counsel in the Litigation & Regulatory Group at DLA Piper LLP (US). Chris litigates high-stakes, complex commercial and corporate governance disputes. Recently, his practice has focused on providing broad-based risk management, litigation and regulatory support to growers, financial institutions,

Chris Gismondi is Of Counsel in the Litigation & Regulatory Group at DLA Piper LLP (US). Chris litigates high-stakes, complex commercial and corporate governance disputes. Recently, his practice has focused on providing broad-based risk management, litigation and regulatory support to growers, financial institutions, manufacturers, distributors and retailers in the tobacco, vape product, and CBD/Hemp industries. He also defends corporate clients against claims for violations of the securities laws, breach of fiduciary duty, and breach of contract. He handles cases before state and federal trial and appellate courts, arbitrators, and mediators, working hand in hand with clients to develop aggressive, yet cost-effective, litigation strategies.

Photo of Jae Yeon Kim Jae Yeon Kim

Jae is a member of DLA Piper’s FDA practice, focusing on regulatory, transactional, and litigation matters impacting clients in the life sciences and consumer products industries. Her broad regulatory practice encompasses a wide range of products, including medical devices, drugs, dietary supplements, foods…

Jae is a member of DLA Piper’s FDA practice, focusing on regulatory, transactional, and litigation matters impacting clients in the life sciences and consumer products industries. Her broad regulatory practice encompasses a wide range of products, including medical devices, drugs, dietary supplements, foods and beverages, alcohol, and cosmetics. She also has experience defending large multinational companies in product liability, false advertising, and commercial litigation.